Clinical Trial Update: Testosterone and Its Metabolites in GID [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating testosterone and its metabolites in individuals with gender dysphoria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gender Dysphoria

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Unita Complessa di Ostetricia e Ginecologia | Conditions: Transsexualism | Phase 3 | Status: COMPLETED